With international travel expected to accelerate over the next few years, more Germans will soon have access to innovative travel vaccines based on a new distribution agreement.
Valneva SE announced today an exclusive three-year agreement with CSL Seqirus for the marketing and distribution of Valneva’s three proprietary vaccines in Germany.
Read More
